Literature DB >> 18955473

Substrains of 129 mice are resistant to Yersinia pestis KIM5: implications for interleukin-10-deficient mice.

Joshua K Turner1, John L Xu, Richard I Tapping.   

Abstract

Interleukin-10 (IL-10)-deficient mice are resistant to several pathogens, including Yersinia pestis. Surprisingly, we observed that heterozygous IL-10(+/-) mice also survive high-dose intravenous infection with Y. pestis KIM5 (Pgm(-)). Analysis of commercial IL-10(-/-) mice revealed that at least 30 cM of genomic DNA from the original 129 strain remains, including a functional Slc11a1 (Nramp1) gene. Interestingly, two substrains of 129 mice were resistant to high-dose Y. pestis KIM5. Resistance does not appear to be recessive, as F(1) mice (C57BL/6J x 129) also survived a high-dose challenge. A QTL-based genetic scan of chromosome 1 with 35 infected F(1) backcrossed mice revealed that resistance to KIM5 maps to a region near IL-10. Two novel IL-10(+/+) mouse strains which each possess most of the original 30-cM stretch of 129 DNA maintained resistance to high-dose infection with Y. pestis KIM5 even in a heterozygous state. Conversely, a novel IL-10(-/-) mouse strain in which most of the 129 DNA has been crossed out exhibited intermediate resistance to KIM5, while the corresponding IL-10(+/-) strain was completely susceptible. Taken together, these results demonstrate that 129-derived genomic DNA near IL-10 confers resistance to Yersinia pestis KIM5 and contributes to the observed resistance of IL-10(-/-) mice.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18955473      PMCID: PMC2612272          DOI: 10.1128/IAI.01057-08

Source DB:  PubMed          Journal:  Infect Immun        ISSN: 0019-9567            Impact factor:   3.441


  26 in total

Review 1.  Interleukin-10 and inhibition of innate immunity to Yersiniae: roles of Yops and LcrV (V antigen).

Authors:  Robert R Brubaker
Journal:  Infect Immun       Date:  2003-07       Impact factor: 3.441

Review 2.  The Yersinia Ysc-Yop 'type III' weaponry.

Authors:  Guy R Cornelis
Journal:  Nat Rev Mol Cell Biol       Date:  2002-10       Impact factor: 94.444

3.  Yersinia enterocolitica evasion of the host innate immune response by V antigen-induced IL-10 production of macrophages is abrogated in IL-10-deficient mice.

Authors:  Andreas Sing; Andreas Roggenkamp; Anna M Geiger; Jürgen Heesemann
Journal:  J Immunol       Date:  2002-02-01       Impact factor: 5.422

4.  Protection of nonobese diabetic mice from diabetes by gene(s) closely linked to IFN-gamma receptor loci.

Authors:  O Kanagawa; G Xu; A Tevaarwerk; B A Vaupel
Journal:  J Immunol       Date:  2000-04-01       Impact factor: 5.422

Review 5.  Knockout mice: simple solutions to the problems of genetic background and flanking genes.

Authors:  David P Wolfer; Wim E Crusio; Hans Peter Lipp
Journal:  Trends Neurosci       Date:  2002-07       Impact factor: 13.837

6.  In vivo comparison of avirulent Vwa- and Pgm- or Pstr phenotypes of yersiniae.

Authors:  T Une; R R Brubaker
Journal:  Infect Immun       Date:  1984-03       Impact factor: 3.441

7.  Haplotype mapping and sequence analysis of the mouse Nramp gene predict susceptibility to infection with intracellular parasites.

Authors:  D Malo; K Vogan; S Vidal; J Hu; M Cellier; E Schurr; A Fuks; N Bumstead; K Morgan; P Gros
Journal:  Genomics       Date:  1994-09-01       Impact factor: 5.736

8.  Contribution of toll-like receptors 2 and 4 in an oral Yersinia enterocolitica mouse infection model.

Authors:  Andreas Sing; Natalia Tvardovskaia; Dagmar Rost; Carsten J Kirschning; Hermann Wagner; Jürgen Heesemann
Journal:  Int J Med Microbiol       Date:  2003-11       Impact factor: 3.473

9.  Suppression of cytokines in mice by protein A-V antigen fusion peptide and restoration of synthesis by active immunization.

Authors:  R Nakajima; V L Motin; R R Brubaker
Journal:  Infect Immun       Date:  1995-08       Impact factor: 3.441

10.  Yersinia V-antigen exploits toll-like receptor 2 and CD14 for interleukin 10-mediated immunosuppression.

Authors:  Andreas Sing; Dagmar Rost; Natalia Tvardovskaia; Andreas Roggenkamp; Agnès Wiedemann; Carsten J Kirschning; Martin Aepfelbacher; Jürgen Heesemann
Journal:  J Exp Med       Date:  2002-10-21       Impact factor: 14.307

View more
  8 in total

1.  Resistance of Mice of the 129 Background to Yersinia pestis Maps to Multiple Loci on Chromosome 1.

Authors:  Michael Tencati; Richard I Tapping
Journal:  Infect Immun       Date:  2016-09-19       Impact factor: 3.441

2.  Resistance to Yersinia pestis infection decreases with age in B10.T(6R) mice.

Authors:  Nathaniel D Lambert; Deanna M Langfitt; Matthew L Nilles; David S Bradley
Journal:  Infect Immun       Date:  2011-08-22       Impact factor: 3.441

Review 3.  Enterobacteria and host resistance to infection.

Authors:  Eugene Kang; Alanna Crouse; Lucie Chevallier; Stéphanie M Pontier; Ashwag Alzahrani; Navoun Silué; François-Xavier Campbell-Valois; Xavier Montagutelli; Samantha Gruenheid; Danielle Malo
Journal:  Mamm Genome       Date:  2018-05-21       Impact factor: 2.957

4.  Interleukin-10 induction is an important virulence function of the Yersinia pseudotuberculosis type III effector YopM.

Authors:  Joseph B McPhee; Patricio Mena; Yue Zhang; James B Bliska
Journal:  Infect Immun       Date:  2012-04-30       Impact factor: 3.441

5.  Difference in Strain Pathogenicity of Septicemic Yersinia pestis Infection in a TLR2-/- Mouse Model.

Authors:  Kyle L O'Donnell; Peter L Knopick; Riley Larsen; Sanghita Sarkar; Matthew L Nilles; David S Bradley
Journal:  Infect Immun       Date:  2020-02-20       Impact factor: 3.441

6.  Model systems to study plague pathogenesis and develop new therapeutics.

Authors:  Matthew B Lawrenz
Journal:  Front Microbiol       Date:  2010-11-04       Impact factor: 5.640

7.  Human Macrophages Clear the Biovar Microtus Strain of Yersinia pestis More Efficiently Than Murine Macrophages.

Authors:  Qingwen Zhang; Youquan Xin; Haihong Zhao; Rongjiao Liu; Xiaoqing Xu; Yanfeng Yan; Zhipeng Kong; Tong Wang; Zhizhen Qi; Qi Zhang; Yang You; Yajun Song; Yujun Cui; Ruifu Yang; Xuefei Zhang; Zongmin Du
Journal:  Front Cell Infect Microbiol       Date:  2019-04-24       Impact factor: 5.293

Review 8.  Pathogenic Exploitation of Lymphatic Vessels.

Authors:  Alexandra I Magold; Melody A Swartz
Journal:  Cells       Date:  2022-03-12       Impact factor: 6.600

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.